- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06844266
Accuracy of the Association Between the "PA-R" and "ACT" Questionnaires in Asthmatic Pediatric Patients (QAS)
February 19, 2025 updated by: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study on the Accuracy of the Association Between the "Physical Activity-Rating" and "Asthma Control Test" Questionnaires in the Anamnestic Evaluation of Asthma Symptom Control in Pediatric Patients
A patient with asthma requires daily and long-term pharmacological treatment when symptoms are frequent and/or severe.
International guidelines suggest increasing or reducing pharmacological therapy based on the individual's needs.
On average, follow-up visits for a child with asthma treated with maintenance pharmacological therapy should be every 3 months.
This period is often challenging to meet in clinical practice because of long waiting lists.
An alternative solution could involve the use of structured questionnaires that the patient should fill out on their own (if aged 12 or older) or with the help of parents (if younger than 12).
A similar solution is also suggested by international asthma guidelines.
The doctor, upon receiving the questionnaire, for example through email, could make the appropriate management decisions and communicate them to the patient, again through email.
For remote use, the test should have optimal sensitivity and specificity, otherwise, there is a risk of either underestimating or overestimating the need for adjustments to the maintenance therapy.
The most commonly used is the Asthma Control Test (ACT), which did non demonstrate an elevated sensibility and specificity as revealed by different studies.
Tripoli et al., for example, reported that 22% of children aged 12 or older with an ACT score = 25 have asthma and a fall in FEV1 >12% after physical exertion.
Considering the information above, we considered combining the ACT with the Physical Activity-Rating (PA-R), a validated questionnaire for measuring the level of physical activity.
It is possible that one of the issues lies in the lack of quantification of the patient's physical activity level when administering the ACT.
Through an interventional study, our intention is to assess the diagnostic accuracy of the ACT + PA-R combination (test under experimentation) compared to ACT (traditional test) and compared to reference standard (spirometry before and after exertion).
The goal of the study is to evaluate whether the combination of a high score in both the PA-R (>7) and ACT (>21) can accurately identify patients with well-controlled asthma, i.e., those with normal spirometry after physical exertion.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
174
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stefano Miceli Sopo
- Phone Number: +390630155701
- Email: Stefano.MiceliSopo@unicatt.it
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Correctly diagnosed asthma;
- Age between 6 and 15 years;
- Understanding and signing of the informed consent by the parent/guardian;
- Understanding and signing of the assent by the minor.
Exclusion Criteria:
- Inability to correctly perform spirometry;
- Inability to correctly perform the exercise test;
- Unwillingness to sign the informed consent by the parent/guardian;
- Unwillingness to sign the assent by the minor.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Asthma Control Test (ACT) + PA-R
Association of "ACT + PA-R" questionnaires
|
The "ACT + PA-R" questionnaires will be administered to pediatric patients with a previously confirmed diagnosis of asthma, who attend the Pediatric Allergy Day Hospital for a routine check-up with spirometry before and after physical exertion.
|
|
Active Comparator: Asthma Control Test (ACT)
ACT questionnaire
|
The "ACT" questionnaire will be administered to pediatric patients with a previously confirmed diagnosis of asthma, who attend the Pediatric Allergy Day Hospital for a routine check-up with spirometry before and after physical exertion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of the reliability of the single ACT test versus the combined test (ACT + PA-R)
Time Frame: 24 months
|
One group of patients will be dministered the ACT test and one group the ACT + PAR test to compare the reliability between the two test and the reference standard (spirometry before and after physical exertion).
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Stefano Miceli Sopo, Fondazione Policlinico Universitario A. Gemelli, IRCCS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 1, 2025
Primary Completion (Estimated)
August 1, 2025
Study Completion (Estimated)
January 1, 2026
Study Registration Dates
First Submitted
February 14, 2025
First Submitted That Met QC Criteria
February 19, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 19, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7190 (CTEP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma in Children
-
Montefiore Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingAsthma in ChildrenUnited States
-
Meyer Children's Hospital IRCCSRecruitingAsthma in Children | Asthma Acute | Asthma Crisis | Asthma ChildhoodItaly
-
University of MiamiEnrolling by invitationAsthma in Children | Artificial IntelligenceUnited States
-
Istituto di Farmacologia Traslazionale - sede di...Not yet recruitingAsthma in Children | Children, Only | Serious Game
-
Children's Hospital of PhiladelphiaNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)CompletedAsthma in ChildrenUnited States
-
ResMedCompletedAsthma in ChildrenUnited States
-
University of WashingtonNational Institute of Environmental Health Sciences (NIEHS); National Institute... and other collaboratorsCompleted
-
Children's Hospital Medical Center, CincinnatiNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
Clinical Trials on Administration of the ACT + PA-R questionnaires
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
University Hospital, LimogesRecruiting
-
Centre Hospitalier Henri LaboritRecruitingPregnancy Related | Eating DisordersFrance
-
Istituto Ortopedico GaleazziTerminated
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Completed
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell UniversityTerminatedRectal Cancer | for Bowel Dysfunction Following Surgery for Rectal CancersUnited States
-
Maastricht University Medical CenterCompletedQuality of Life | Satisfaction, Patient | Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of Head and Neck | Skin Cancer | Squamous Cell Carcinomas | Squamous Cell Carcinoma of the Skin | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell Carcinoma | High-Risk CancerNetherlands
-
Northwestern UniversityNational Institute on Minority Health and Health Disparities (NIMHD); National...Completed
-
Casa di Cura Dott. PederzoliRecruiting